| 000 | 01722 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512203347.0 | ||
| 264 | 0 | _c19841205 | |
| 008 | 198412s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1016/0002-8703(84)90754-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKereiakes, D J | |
| 245 | 0 | 0 |
_aMechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cNov 1984 |
||
| 300 |
_a1278-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Volume _xdrug effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aEnoximone |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitral Valve Insufficiency _xphysiopathology |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aPulmonary Wedge Pressure _xdrug effects |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aViquerat, C | |
| 700 | 1 | _aLanzer, P | |
| 700 | 1 | _aBotvinick, E H | |
| 700 | 1 | _aSpangenberg, R | |
| 700 | 1 | _aBuckingham, M | |
| 700 | 1 | _aParmley, W W | |
| 700 | 1 | _aChatterjee, K | |
| 773 | 0 |
_tAmerican heart journal _gvol. 108 _gno. 5 _gp. 1278-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-8703(84)90754-3 _zAvailable from publisher's website |
| 999 |
_c6238491 _d6238491 |
||